Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
4
×
national blog main
national top stories
new york top stories
boston blog main
boston top stories
fda
new york blog main
san francisco top stories
drugs
national
roche
san diego blog main
san diego top stories
san francisco blog main
allergan
allopregnanolone
billy dunn
biogen
biotech
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
bristol-myers squibb
cancer
clinical data
companion diagnostic
detroit blog main
detroit top stories
dna sequencing
drug prices
drug pricing
entrectinib
europe top stories
evrysdi
express scripts
foundation medicine
What
approved
4
×
drug
medicine
4
×
new
4
×
fda
oks
atrophy
brexanolone
cancer
daily
data
deeper
depression
devastating
disease
disorder
dna
evrysdi
fast
fatty
fingerprint
friday
genetic
going
green
home
horizon
intended
intercept
known
lights
liquid
liver
marketed
matter
moms
muscular
nash
nd
nonalcoholic
Language
unset
Current search:
approved
×
medicine
×
new
×
" life sciences "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues